CARPA
"Next-Generation Measurement Assay for Nanomedicine"
Complement-activation related pseudoallergy (CARPA) is a potentially lethal acute immune toxicity caused by many intravenous drugs that contain nanoparticles or proteins. The integration of our group’s biomimetic membrane platform with state-of-the-art surface-based characterization tools has led to a promising new approach for real-time monitoring and better understanding of the complement activation process.
06
Fülöp TG, Nemes R, Mészáros T, Urbanics R, Kok RJ, Jackman JA, Cho NJ, Storm G, Szebeni J
​
Journal of Controlled Release 2017; 270, 268-274.
05
Yorulmaz Avsar S, Jackman JA, Kim MC, Yoon BK, Hunziker W, Cho NJ
​
Langmuir 2017; 33(29), 7332-7342.
04
Yorulmaz S, Jackman JA, Hunziker W, Cho NJ
​
Colloids and Surfaces B: Biointerfaces 2016; 148, 270-277.
03
Jackman JA, Mészáros T, Fülöp T, Urbanics R, Szebeni J*, Cho NJ*
​
Nanomedicine: Nanotechnology, Biology, and Medicine 2016; 12(4), 933-943.
02
Yorulmaz S, Jackman JA, Hunziker W, Cho NJ
Biomacromolecules 2015; 16(11), 3594-3602.
01
Yorulmaz S, Tabaei SR, Kim MH, Seo JE, Hunziker W, Szebeni J, Cho NJ
​
European Journal of Nanomedicine 2015; 7(3), 245-255.